Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Bone. 2020 Dec 9;144:115789. doi: 10.1016/j.bone.2020.115789

Figure 4. Validation Workflow of in vivo RNA-Seq., scRNA-Seq. or miR Microarray potential targets (compare Control vs miR knockdown, miR OE or inducible (conditional) miR inactivation).

Figure 4.

• Note- In situ hybridization for gene and miR transcripts may not yield accurate information as miRs and miR targets may not be degraded upon miR inhibition or over expression (OE), respectively.